The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Bio-Techne Corporation (TECH) is a Minnesota-based life sciences company with a 50-year history of serving the scientific research and diagnostics industries. The company develops and supplies ...

Merck KGaA, Darmstadt, Germany, and Bio-Techne announced they entered into a definitive agreement under which Merck KGaA will acquire Bio-Techne for $73 per share in cash. The transaction represents a ...

Bio-Techne (TECH) rose 4% on a report that activist investor Ananym Capital Management has accumulated a stake in the maker of life-sciences tools and wants the company to pursue a strategic review, ...

Bio-Techne Corporation today announced that Advanced Cell Diagnostics (ACD), part of Bio-Techne's Spatial Biology Division, has surpassed 10,000 peer-reviewed publications referencing the use and ...

Bio-Techne faces near-term growth headwinds from challenges in academic and biotech research funding, but retains strong leverage to growing spatial biology, proteomics, and cell/gene therapy research ...

Activist investor Ananym Capital Management has built a stake in Bio-Techne Corp. and is pushing the board to conduct a strategic review that would include a potential sale. Ananym said in a letter ...

The life sciences tools and services sector is back in focus after Merck KGaA (MKGAF) agreed to acquire Bio-Techne (TECH) for $73 per share in cash, valuing the deal at an enterprise value of around ...

Activist Ananym builds stake in Bio-Techne (NASDAQ: TECH), urges ... This is a premium only article. To continue reading this and other premium stock market news ...